Breaking AI & Tech News Analyzed

The chasm between Silicon Valley's tech elite and everyday people is growing ever larger, as the industry doubles down on artificial intelligence. Nvidia's CEO Jensen Huang predicts $1tn in sales by 2028, a staggering figure that equates to 3% of the entire US yearly GDP.Meanwhile, 65% of Americans don't use AI in their work at all, according to Pew Research. The survey also shows that Americans are wary of AI and believe both political parties are regulating it poorly. Meta is reallocating huge amounts of its spending to AI, cutting jobs and scaling back metaverse ambitions. The company's Reality Labs division has recorded losses of $80bn since 2020.In a stark illustration of the divide, Mark Zuckerberg is building an AI agent to perform his work as CEO of Meta. The AI industry is splitting away from the lives of everyday people, with exclusive polling conducted for the Guardian finding that twice as many Americans believe their financial security is getting worse than better.In other tech news, Tesla's Cybertruck has been involved in several fiery crashes, resulting in fatalities and lawsuits. The vehicle's unique design and materials have raised safety concerns, with experts alleging that the truck's design led to these worst-case scenarios.

A recent conversation with a guest at an academic function brought to light the public's desire for a simple, all-encompassing test for cancer. The guest, intrigued by the speaker's profession as an oncologist, inquired about the existence of an 'everything' test for cancer. The speaker's response was clear: no such test exists.The quest for early cancer detection is a significant goal in cancer medicine, with the aim of identifying the disease before it metastasizes and ensuring a cure. One company, Grail, launched a blood test called Galleri, which claims to detect a 'signal' shared by more than 50 types of cancer. This signal is identified through circulating DNA, minute fragments of cancer DNA present in the bloodstream.The Galleri test was marketed as a screening tool, with results indicating either a cancer signal detected or no cancer signal detected. However, the test failed to meet its primary endpoint in a large-scale trial conducted with the NHS, which aimed to determine if the test could reduce late-stage cancer diagnoses. Despite the company's claims of 'strong' results, the trial did not demonstrate a significant reduction in late-stage cancer diagnoses.The failure of the Galleri test highlights a crucial distinction between detecting more cancers and saving lives. Detecting cancer at an early stage does not necessarily translate to less invasive treatments or prolonged survival. Moreover, some cancers detected through screening may never have posed a lethal threat, leading to unnecessary interventions.For now, there is no blood test or total body scan that saves lives. Instead, the focus should be on modifying cancer risk factors, such as reducing processed foods, curbing alcohol consumption, quitting smoking, and engaging in regular exercise. These evidence-based approaches may not be as flashy as a single 'everything' test, but they have a proven impact on public health.

Iga Swiatek, the world No 3 tennis player, has spoken candidly about her struggles after a difficult defeat at the Miami Open. The Polish player lost to her compatriot Magda Linette in a messy three-set affair, marking one of her most challenging losses in years. In a post-match media session, Swiatek broke down in tears, highlighting the emotional toll of her recent performances. She described her current situation as 'the worst nightmare a top tennis player can have,' struggling to cope with the pressure and weight of her achievements. Swiatek's issues on the court have been compounded by her mental state. Despite being a six-time grand slam title winner and one of the greatest players of her generation, she has been plagued by chronic overthinking, worrying, and second-guessing her decisions. The problems began in the autumn of 2024 after a positive test for the banned substance trimetazidine, which led to a month-long suspension. Although she proved the substance was in a permitted sleep medication, the incident affected her performance. Swiatek's inactivity in the final months of 2024 meant she couldn't regain her No 1 ranking, which has been held by her rival Aryna Sabalenka. In a bid to address her struggles, Swiatek has parted ways with her coach, Wim Fissette. Her partnership with sports psychologist Daria Abramowicz has been crucial in her career, but Swiatek may need to take more ownership of her decision-making to move forward. Despite her current challenges, Swiatek remains a formidable player, known for her destructive groundstrokes, heavy topspin, and supreme athleticism. Her mental toughness has been a key factor in her success, but it has also become a source of stress in recent months.

A New Mexico jury has ordered Meta to pay $375m in civil penalties after finding the company liable for misleading consumers about the safety of its platforms and enabling harm, including child sexual exploitation. This verdict marks the first bench trial to find Meta liable for acts committed on its platform. The lawsuit, brought by New Mexico Attorney General Raúl Torrez, claimed that Meta executives knew their products harmed children but disregarded warnings from their own employees and lied to the public about the risks. The jury found Meta liable for violating New Mexico's consumer protection laws, specifically the Unfair Practices Act. The penalty of $375m is the maximum allowed under the law of $5,000 per violation. Meta has announced its intention to appeal the ruling, accusing Torrez of making 'sensationalist, irrelevant arguments.' Internal Meta documents and testimony revealed that company employees and external child safety experts repeatedly warned about risks on Meta's platforms. Evidence presented included details of a sting investigation, 'Operation MetaPhile,' which led to the arrest of three men charged with sexually preying on children through Meta's platforms. The New Mexico court also heard about deficiencies in Meta's reporting of crimes on its platforms, including the exchange of child sexual abuse material. Meta generated high volumes of 'junk' reports by overly relying on AI to moderate its platforms, making it difficult for law enforcement to investigate crimes. In the next phase of the legal proceedings, the attorney general's office will seek additional financial penalties and court-mandated changes to Meta's platforms to offer stronger protections for children. The state is seeking design feature changes, including 'enacting effective age verification, removing predators from the platform, and protecting minors from encrypted communications.' This verdict is seen as a 'historic victory' for children and families who have been affected by Meta's actions. The case may also open the floodgates to further litigation and regulation of social media companies.

Handel's mid-career novelty, Imeneo, is a comedy of duty and desire that defies conventions. Unlike Mozart's Così fan tutte, Imeneo eschews cynicism and cruelty, instead opting for a lighthearted, meta-theatrical approach.Director Guido Martin-Brandis and the Cambridge Handel Opera Company bring this operetta to life with a delightful staging that captures its knowing, self-referential charm. The set design, featuring a row of Ionic columns and an 18th-century fantasy of topiary and trellis, perfectly complements the opera's playful nature.The story follows Imeneo (played by Timothy Nelson), who rescues the city's marriageable young virgins from pirate-kidnappers. The conflict revolves around Rosmene (played by Ellie Neate), who must choose between gratitude and fidelity. Handel's music, conducted by Julian Perkins from the harpsichord, is a precise cocktail of artifice and sincerity, beautifully balanced by the cast.The cast delivers outstanding performances, with Neate's Rosmene growing in power throughout the final scene, and Lisa Dafydd's Clomiri captivating audiences with her sweet singing. Bethany Horak-Hallett's mezzo and Nelson's baritone are evenly matched, while Trevor Eliot Bowes brings comic relief as the patriarch Argenio.This production of Imeneo is a must-see, with its witty and careful handling of Handel's music and libretto. Don't miss it, running until March 28.

Scientists have made a groundbreaking discovery that could lead to the development of new obesity drugs. By studying the unique metabolic abilities of pythons, researchers have identified a molecule that appears to play a crucial role in regulating appetite and weight loss. The molecule, called pTOS, was found to increase significantly in the blood of pythons after they eat, and when administered to obese mice, it led to a significant reduction in food intake and a 9% loss of body weight over 28 days. The discovery could lead to the development of new obesity drugs that work in a different way to existing medications, such as GLP-1 medications like Wegovy. Unlike these medications, which can have side effects such as nausea and stomach pain, pTOS appears to act on the brain's appetite centers, reducing food intake without these adverse effects. The researchers, led by Dr. Jonathan Long from Stanford University and Prof. Leslie Leinwand from the University of Colorado Boulder, published their findings in the journal Nature Metabolism. They believe that pTOS, which is naturally produced by the snake's gut bacteria and also found in human urine, could be a safe and effective treatment for obesity. While further research is needed before the findings can be applied clinically, the discovery is seen as a promising step towards the development of new obesity treatments. The study's results suggest that pTOS could be a potential therapeutic target for the treatment of obesity and related metabolic disorders.

In 1986, thrash metal reached a critical point with landmark albums from Slayer, Megadeth, and Metallica. However, across the Atlantic, a group of teenagers were forging their own path in the genre. Kreator, Sodom, Destruction, and Tankard, dubbed the 'big four' of German thrash metal, were faster and meaner than their American counterparts.These bands made up for their lack of finesse and professionalism with sheer aggression. Destruction vocalist and bassist Marcel 'Schmier' Schirmer notes that they focused on writing songs that 'punched hard' rather than striving for musical perfection.The German thrash metal scene was marked by its rough and violent approach, with bands drawing inspiration from English heavy metal albums and American thrash metal bands like Slayer. The scene was also influenced by the political climate of the time, with the presence of the Berlin Wall and the Cold War.Bands like Formel 1 from East Germany, who released their live album Live Im Stahlwerk in 1986, were also part of the thriving metal scene. Despite the challenges faced by these bands, including limited resources and censorship, they managed to create a lasting impact on the metal genre.Today, bands like Kreator, Sodom, and Destruction continue to tour and produce new music, with Kreator's 16th album, Krushers of the World, and Destruction's upcoming US tour with Overkill and Testament. The legacy of German thrash metal remains strong, with its unbridled aggression and brutal sound continuing to influence metal musicians to this day.